Trial · NCT01044771
Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
NCT01044771, Not applicable, Completed, Metropolis Medical; results first posted 2015-05-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria. Trials, record NCT01044771. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01044771
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Pilot Study of Raltegravir Switch to Resolve Tenofovir Induced Proteinuria
- NCT number
- NCT01044771
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 20 participants, actual
- Lead sponsor
- Metropolis Medical
- Conditions
- HIV Infections, Proteinuria
- Interventions
- change from tenofovir to raltegravir
- First posted
- 2010-01-08
- Last updated
- 2015-05-12
- Results first posted
- 2015-05-12
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Patients With Reduced or Resolved Proteinuria | 24 weeks | Measurement of Protein in Urine samples at end of study visit |
| Secondary | Patients Without HIV Re-bound | 24 weeks | HIV Viral load blood test at week 24 |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Patients With Reduced or Resolved Proteinuria | 24 weeks | participants | NUMBER | |
| SECONDARY | Patients Without HIV Re-bound | 24 weeks | Subjects entered with undetectable Viral Load and Proteinuria | participants | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Patients With Reduced or Resolved Proteinuria | Change From Tenofovir to Raltegravir | 20 | participants | ||
| Patients Without HIV Re-bound | Viral Rebound | 2 | participants |
Source ClinicalTrials.gov
Participant flow3
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Change From Tenofovir to Raltegravir | 20 | |
| Overall Study | COMPLETED | Change From Tenofovir to Raltegravir | 20 | |
| Overall Study | NOT COMPLETED | Change From Tenofovir to Raltegravir | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals3
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Change From Tenofovir to Raltegravir | ||
| Total, other adverse events | Change From Tenofovir to Raltegravir | 0 | 20 |
| Total, serious adverse events | Change From Tenofovir to Raltegravir | 0 | 20 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01044771
GET https://conductscience.org/api/trials/v1/NCT01044771/registered